Clinical Trials Browser

Head and Neck Neoplasms

NCT02624128 2023-11-13

V-CHANCE

Phase 2 Unknown

39 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Neoplasm Metastasis, Recurrence

NCT04359199 2023-02-10

QUASAR

Unknown

42 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Deglutition Disorders, Head and Neck Neoplasms, Oropharyngeal Neoplasms

NCT03552406 2021-05-06

Study of ISU104, Targeting ERBB3 in Patients With Advanced Solid Tumors

Phase 1 Unknown

33 enrolled

BreastHead & Neck

Breast Neoplasms, Head and Neck Neoplasms

NCT03051906 2017-11-22

DUCRO-HN

Phase 1/2 Unknown

69 enrolled

Head & Neck

Carcinoma, Squamous Cell, Head and Neck Neoplasms

NCT01472653 2011-12-13

Treatment Selection According to Skin Reaction to Cetuximab

Phase 2 Unknown

120 enrolled

Head & Neck

Head and Neck Neoplasms

NCT01301248 2011-05-17

Cisplatin Chemoradiation With or Without Cetuximab for Locoregionally Advanced Squamous Cell Carcinomas (SCC) of the Head and Neck

Phase 2 Unknown

80 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT01166035 2010-07-20

TEXO

Phase 1/2 Unknown

20 enrolled

GastrointestinalHead & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Colorectal Neoplasms

Clinical Trials

Palbociclib With Cetuximab and IMRT for Locally Advanced Squamous Cell Carcinoma

V-CHANCE

QUASAR

Study of ISU104, Targeting ERBB3 in Patients With Advanced Solid Tumors

DUCRO-HN

Treatment Selection According to Skin Reaction to Cetuximab

Cisplatin Chemoradiation With or Without Cetuximab for Locoregionally Advanced Squamous Cell Carcinomas (SCC) of the Head and Neck

TEXO